Author | Linda T. Vahdat, MD | OncLive

Author | Linda T. Vahdat, MD

Articles

Dr. Vahdat on Frontline Eribulin Plus Trastuzumab in MBC

February 26, 2013

Video

Linda T. Vahdat, MD, from the Weill Cornell Medical College, discusses the combination of eribulin mesylate and trastuzumab as a first-line therapy for HER2-positive metastatic breast cancer.

Dr. Vahdat Discusses the Side Effects of Halaven

January 18, 2012

Video

Dr. Linda Vahdat, from New York-Presbyterian Hospital, Discusses the Side Effects of Halaven

Dr. Vahdat Compares Halaven and Ixempra Neuropathy

December 22, 2011

Video

Dr. Linda Vahdat, from the New York-Presbyterian Hospital, Compares Halaven and Ixempra Neuropathy

x